Patents by Inventor Lisa Beavers

Lisa Beavers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070208024
    Abstract: The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds.
    Type: Application
    Filed: March 25, 2005
    Publication date: September 6, 2007
    Inventors: Lisa Beavers, Don Finley, Terry Finn, Robert Gadski, Philip Hipskind, William Hornback, Cynthia Jesudason, Richard Pickard, Takako Takakuwa, Grant Vaught
  • Publication number: 20070197604
    Abstract: The present invention discloses novel aryl oxazole compounds of Formula I (I), or pharmaceutically acceptable salts thereof, which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing and using such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using these compositions to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
    Type: Application
    Filed: July 14, 2005
    Publication date: August 23, 2007
    Inventors: Lisa Beavers, Serge Boulet, Terry Finn, Robert Gadski, Willaim Hornback, Cynthia Jesudason, Richard Pickard, Freddie Stevens, Grant Vaught
  • Publication number: 20070155754
    Abstract: The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
    Type: Application
    Filed: February 22, 2005
    Publication date: July 5, 2007
    Inventors: Lisa Beavers, Robert Gadski, Philip Hipskind, Cynthia Jesudason, Karen Lobb, Richard Pickard, Craig Lindsley
  • Publication number: 20060167046
    Abstract: The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine-II3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I), as well as methods or using them to treat obesity and other histamine II3 receptor-related diseases.
    Type: Application
    Filed: September 12, 2003
    Publication date: July 27, 2006
    Applicant: Eli Lilly and Company Patent Division
    Inventors: Lisa Beavers, Don Finley, Robert Gadski, Philip Hipskind, Cynthia Jesudason, Richard Pickard, Freddie Stevens
  • Publication number: 20060089347
    Abstract: The present invention discloses novel substituted azepine compounds of Formula (I) or pharmaceutically acceptable salts thereof which have selective histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such azepines as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
    Type: Application
    Filed: August 15, 2003
    Publication date: April 27, 2006
    Applicant: Eli Lilly and Company
    Inventors: Robert Gadski, Phillip Hipskind, Cynthia Jesudason, Richard Pickard, Lisa Beavers, Christopher Sledem, Alay Singh